A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide

INTRODUCTION: Irbesartan, a diazaspiro angiotensin II blocker, is marketed in combination with Hydrochlorothiazide, which is a diuretic acting on distal convoluted tubule; for synergistic anti-hypertensive action. The present study deals with development and validation of a stability indicating HPTL...

Descripción completa

Detalles Bibliográficos
Autores principales: Khodke, Amol S, Potale, Laxman V, Damle, Mrinalini C, Bothara, Kailash G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658016/
https://www.ncbi.nlm.nih.gov/pubmed/23781414
http://dx.doi.org/10.4103/2229-4708.72229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658016/
https://www.ncbi.nlm.nih.gov/pubmed/23781414
http://dx.doi.org/10.4103/2229-4708.72229

Ejemplares similares